Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 20 min ago
Peer-reviewedCC BY 4.0Frontiers in Oncology

Editorial: E3 ubiquitin ligases: critical roles in cancer progression and therapeutic implications

  1. 1Cancer Genome and Epigenetics Program, Sanford Burnham Prebys Medical Discovery Institute
  2. 2Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
  3. 3Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill

Related

  1. NEDD4 Promotes Hepatocellular Carcinoma Progression Through Ubiquitin-Dependent Degradation of EPHB6.
    Guowei Zhang, Mengxuan Ji, Zhiyi Liu +8
    Cancer sciencePeer-reviewedCC BY-NCFull textMolecular biology & gene regulationEurope PMCPMC
  2. Ubiquitin-conjugating enzyme E2S promotes the progression of lung adenocarcinoma through the NF-κB/GATM signaling axis
    Zhi Liu, Zhiqiang Han, Dong Wang +2
    European Journal of Medical ResearchPeer-reviewedCC BYFull textMolecular biology & gene regulationDOAJ
  3. Ubiquitin-specific proteases and the immune microenvironment in cervical cancer: mechanistic evidence, immunotherapy resistance, and therapeutic perspectives
    Yanhua Zhang, Liling Zhu, Lei Xia +3
    Neoplasia (New York, N.Y.)Peer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationPMC
  4. Editorial: Decoding the gut-brain axis: implications for neurodegenerative disease therapies
    R. M. Damian Holsinger, R. M. Damian Holsinger
    Frontiers in Aging NeurosciencePeer-reviewedCC BYFull textMolecular biology & gene regulationDOAJ
  5. Editorial: The role of RNA regulation in cancer pathogenesis and therapeutic strategies
    Senn Wakahashi, Maho Azumi, Kentaro Minagawa
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossref
BibTeX
@article{koganti2026editorial,
  title = {{Editorial: E3 ubiquitin ligases: critical roles in cancer progression and therapeutic implications}},
  author = {Praveen Koganti and Pengda Liu},
  journal = {Frontiers in Oncology},
  year = {2026},
  month = oct,
  doi = {10.3389/fonc.2026.1995835},
  url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.1995835/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Editorial: E3 ubiquitin ligases: critical roles in cancer progression and therapeutic implications
AU  - Praveen Koganti
AU  - Pengda Liu
PY  - 2026
DA  - 2026/10/01
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2026.1995835
UR  - https://www.frontiersin.org/articles/10.3389/fonc.2026.1995835/full
SN  - 2234-943X
ER  -